scholarly journals Management of the National Drug Administration Through the Use of Biosimilar Medicines. Expenditures, Numbers of Reimbursed Packages and Shares of Biosimilar Products in the Infliximab Market a Year Prior to and a Year after the Introduction of the National Drug Policy 2018–2022

2020 ◽  
Vol 2/2020 (88) ◽  
pp. 121-138
Author(s):  
Olga Barszczewska ◽  
◽  
Anna Piechota ◽  
Jadwiga Suchecka ◽  
◽  
...  
Keyword(s):  
Drug Administration ◽  
Drug Policy ◽  
National Drug ◽  
National Drug Policy

Management of the National Drug Administration Through the Use of Biosimilar Medicines. Expenditures, Numbers of Reimbursed Packages and Shares of Biosimilar Products in the Infliximab Market a Year Prior to and a Year after the Introduction of the National Drug Policy 2018–2022

scholarly journals Barriers and facilitators to adherence to national drug policies on antibiotic prescribing and dispensing in Bangladesh

2021 ◽  
Vol 14 (S1) ◽  
Author(s):  
Fosiul Alam Nizame ◽  
Dewan Muhammad Shoaib ◽  
Emily K. Rousham ◽  
Salma Akter ◽  
Mohammad Aminul Islam ◽  
...  
Keyword(s):  
Drug Policy ◽  
Group Discussion ◽  
National Policy ◽  
Barriers And Facilitators ◽  
Drug Shop ◽  
Antibiotic Prescribing ◽  
National Drug ◽  
National Drug Policy ◽  
Drug Policies ◽  
The Government

Abstract Background The National Drug Policy in Bangladesh prohibits the sale and distribution of antibiotics without prescription from a registered physician. Compliance with this policy is poor; prescribing antibiotics by unqualified practitioners is common and over-the-counter dispensing widespread. In Bangladesh, unqualified practitioners such as drug shop operators are a major source of healthcare for the poor and disadvantaged. This paper reports on policy awareness among drug shop operators and their customers and identifies current dispensing practices, barriers and facilitators to policy adherence. Methods We conducted a qualitative study in rural and urban Bangladesh from June 2019 to August 2020. This included co-design workshops (n = 4) and in-depth interviews (n = 24) with drug shop operators and customers/household members, key informant interviews (n = 12) with key personnel involved in aspects of the antibiotic supply chain including pharmaceutical company representatives, and model drug shop operators; and a group discussion with stakeholders representing key actors in informal market systems namely: representatives from the government, private sector, not-for-profit sector and membership organizations. Results Barriers to policy compliance among drug shop operators included limited knowledge of government drug policies, or the government-led Bangladesh Pharmacy Model Initiative (BPMI), a national guideline piloted to regulate drug sales. Drug shop operators had no clear knowledge of different antibiotic generations, how and for what diseases antibiotics work contributing to inappropriate antibiotic dispensing. Nonetheless, drug shop operators wanted the right to prescribe antibiotics based on having completed related training. Drug shop customers cited poor healthcare facilities and inadequate numbers of attending physician as a barrier to obtaining prescriptions and they described difficulties differentiating between qualified and unqualified providers. Conclusion Awareness of the National Drug Policy and the BPMI was limited among urban and rural drug shop operators. Poor antibiotic prescribing practice is additionally hampered by a shortage of qualified physicians; cultural and economic barriers to accessing qualified physicians, and poor implementation of regulations. Increasing qualified physician access and increasing training and certification of drug shop operators could improve the alignment of practices with national policy.

História do Medicamento Genérico no Brasil

2019 ◽  
Vol 22 (2) ◽  
pp. 119
Author(s):  
Erick De Oliveira Lemes ◽  
Naara Sabrine Vaz de Almeida ◽  
Paulo Henrique Pires Eubanks ◽  
Sebastião Robson de Resende ◽  
Wanessa Cristina Martins da Luz
Keyword(s):  
Federal Government ◽  
Active Ingredient ◽  
Drug Policy ◽  
Generic Medicine ◽  
Generic Medicines ◽  
Awareness Campaigns ◽  
National Drug ◽  
National Drug Policy ◽  
History Of ◽  
The Right

Os medicamentos são considerados indispensáveis à saúde, ocupando o centro das atenções na atualidade, uma vez que seu modo de utilizaçãoreflete o efeito terapêutico. Os medicamentos genéricos estão disponíveis em preços acessíveis, graças à Política Nacional de Medicamentos (PNM), que passou a ser implementada pelo Governo Federal desde 1999 para que houvesse possibilidades de escolhas para os pacientes na aquisição de medicamentos de qualidade. Os medicamentos genéricos podem ser intercambiáveis com os de referências, quando está escrito na receita médica o nome do princípio ativo. Este trabalho teve como objetivo descrever a história dos genéricos no Brasil, a fim de contribuir com informações acerca da importância destes medicamentos e segurança na utilização pela população, desmitificando o fato de serem mais baratos em decorrência da falta de qualidade, eficácia ou segurança. Esta investigação foi caracterizada como pesquisa bibliográfica, a amostra em estudo foi composta por um conjunto de publicações contidas em periódicos, livros-textos, monografias, dissertações e teses. Com a realização deste estudo foi possível aferir que o medicamento genérico é tão relevante quanto o de referência. As pessoas necessitam saber as vantagens em se adquirir os medicamentos genéricos, por meio de campanhas de conscientização, bem como ter conhecimento de que o genérico tem o mesmo princípio em relação ao de referência. Campanha de conscientização se faz necessária para a população a respeito dos medicamentos genéricos.Palavras-chave: Medicamento. Segurança. BioequivalênciaAbstractMedicines are considered indispensable to health, occupying the center of attention nowadays, its mode of use reflects the therapeutic effect.Generic medicines are available at affordable prices thank to the national drug policy, which has been implemented by the Federal Government since 1999 so that there are possibilities for patients to choose the right medicines. Generic medicines can be interchangeable with those of reference when the name of the active ingredient is written on the prescription. This work aimed to describe the history of generics in Brazil, in order to contribute information about the importance of these drugs and safety in use by the population, demystifying the fact that they are cheaper due to the lack of quality, effectiveness or safety. This research was characterized as a bibliographic research, the study sample was composed by a set of publications contained in periodicals, textbooks, monographs, dissertations and theses. With the accomplishment of this study it was possible to verify that the generic medicine is as relevant as the reference. People need to know the advantages in acquiring generic medicines through awareness campaigns, as well as being aware that the generic has the same principle in relation to the reference. Awareness campaigns are necessary for the population regarding generic medicines.Keywords: Medications. Safety. Bioequivalence

National Drug Policy in Nigeria

1992 ◽  
Vol 13 (3) ◽  
pp. 367 ◽  
Author(s):  
O. Ransome Kuti
Keyword(s):  
Drug Policy ◽  
National Drug ◽  
National Drug Policy

New Zealand's national drug policy

1999 ◽  
Vol 18 (4) ◽  
pp. 435-440
Author(s):  
M. B. WEBB
Keyword(s):  
Drug Policy ◽  
National Drug ◽  
National Drug Policy
Sign in / Sign up

Export Citation Format

Share Document